Related Experiment Videos
Identification of human complement factor H as a chemotactic protein for monocytes
1Institut National de la Santé et de la Recherche Médicale, Unité 14, CHU Brabois, Vandoeuvre Les Nancy, France.
The Biochemical Journal
|September 18, 1997
Summary
Researchers identified complement factor H (CFH) in mesothelioma effusions as a potent monocyte chemoattractant. This finding reveals CFH’s novel role in immune cell recruitment and links humoral and cellular immunity in cancer.
Area of Science:
- Immunology
- Biochemistry
- Oncology
Background:
- Mesothelioma is a rare cancer with limited treatment options.
- The tumor microenvironment in mesothelioma involves complex immune interactions.
- Understanding immune cell recruitment in mesothelioma is crucial for developing new therapies.
Purpose of the Study:
- To identify chemotactic proteins within mesothelioma pleural effusions.
- To elucidate the role of identified proteins in immune cell recruitment.
- To explore the potential therapeutic implications of these findings.
Main Methods:
- Chromatographic separation was used to purify proteins from mesothelioma pleural effusions.
- N-terminal amino acid sequencing and immunoblotting were employed for protein identification.
- Functional assays using specific antibodies were performed to assess chemotactic activity.
Main Results:
- A 150 kDa monomeric protein was purified and identified as complement factor H (CFH).
- Purified CFH exhibited significant monocyte chemotactic activity, with optimal activity at 10 nM.
- Antibodies against CFH inhibited the observed monocyte chemotactic activity.
Conclusions:
- Complement factor H possesses a novel function as a chemoattractant for monocytes in the context of mesothelioma.
- This chemotactic activity may contribute to malignant cell phagocytosis through the iC3b/complement receptor type 3 pathway.
- These findings highlight a link between the humoral and cellular immune systems in mesothelioma pathogenesis.